News

News from the PANGEA study at Dana-Farber Cancer Institute: Which Smoldering Myeloma (SMM) Patients Are More Likely to Progress? Inside the PANGEA-SMM Model.

The PANGEA Model is a tool that helps patients predict their personal risk of developing myeloma within the next 1 to 10 years (The Pangea Model - SMM Risk Calculator). The model incorporates both patients' most recent lab results and their lab history from the past two years to provide a more individualized risk estimate. The PANGEA model is available to anyone who wants to use it on the website. Read the Nature Medicine paper describing the model here. Learn how the PANGEA

Katie Couric Helps Spread the Word About Why Blood Cancer is Often Diagnosed Too Late

See the Story on Katie Couric's Website here. Katie Couric has spent many years advocating for patients with cancer. In a recent...

Smoldering Multiple Myeloma - To Treat Or Not To Treat

VIDEO: 3:26 Minutes Even when people are not experiencing symptoms, it is important to consider the outcomes research when deciding...

Research Updates on Smoldering Multiple Myeloma - Dr. Mark Bustoros

Video: 30:34 Minutes A Professional Presentation From Dana-Farber Cancer Institute Mark Bustoros, MD of the Dana Farber Cancer Institute,...